Recent studies have already shown that kinase inhibition can alleviate mitochondrial dysfunction in mouse models of mitochondrial disease by dampening mTOR, PKC, or AMPK signaling (51, 52, 53). This evidence concerns the gene MTOR and inborn mitochondrial metabolism disorder.